Categories
Mangalam Drugs And Organics Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting
14-05-2026 · 06:10 pm
Mangalam Drugs' board approved consolidated financial results for Q4 & FY26, reporting Rs 232.13 Cr revenue and Rs 44.40 Cr net loss for FY26. A merger scheme hearing with NCLT is set for June 2, 2026.
No comments yet. Be the first to comment!